Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study

被引:3
|
作者
Ghosh, Subrata [1 ,2 ]
Antunes, Ana [3 ,9 ]
Rinta-Kokko, Hanna [4 ]
Chaparova, Elena [5 ]
Lay-Flurrie, Sarah [6 ]
Tricotel, Aurore [7 ]
Andersson, Fredrik L. [8 ]
机构
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] Univ Birmingham, Birmingham, England
[3] IQVIA, Real World Solut, Global Database Studies, Lisbon, Portugal
[4] IQVIA, Real World Solut, Global Database Studies, Espoo, Finland
[5] IQVIA, Real World Solut, Sofia, Bulgaria
[6] IQVIA, Real World Solut, London, England
[7] IQVIA, Real World Solut, Paris, France
[8] Ferring Pharmaceut, Copenhagen, Denmark
[9] IQVIA, Lagoas Pk,Edificio 3, P-2740266 Lisbon, Portugal
关键词
Clostridioides difficile infection; Recurrent clostridioides difficile infection; Epidemiological; Real-world study; England; RECUR; RISK; DISEASE;
D O I
10.1016/j.ijid.2024.01.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To estimate the epidemiological and clinical burden of Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in England. Methods: This retrospective study included adult patients diagnosed with CDI (community or hospital settings) over 2015-2019 from Clinical Practice Research Datalink and Hospital Episode Statistics databases. Incidences of CDI and rCDI were determined annually. Time to subsequent rCDI was estimated by Kaplan-Meier method. Rates of complications were assessed within 12 months from index episode. Association of risk factors with complications was evaluated using a Cox regression model. Results: A total of 52,443 CDI episodes were recorded among 36,913 patients. Of these, 75% were aged >= 65 years, 59% were women; 73% were treated in community settings. CDI incidence remained stable (111 episodes per 10 0,0 0 0 patients in 2019). Around 21% of patients had >= 1 rCDI. Sepsis (12%) was the most common complication, followed by colectomy and ulcerative colitis. Age, gender, comorbidities, rCDI, preindex medical procedures, hospitalizations and consultations, and CDI treatment in hospital, were found to increase the risk of complication. Conclusions: CDI remains a concern in England. The study highlights the importance of managing primary and rCDI episodes via effective and improved therapies to prevent fatal complications. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [21] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [22] CEFTOLOZANE-TAZOBACTAM FOR THE TREATMENT OF COMPLICATED INFECTIONS IN HOSPITAL SETTINGS - RESULTS FROM A FRENCH REAL-WORLD STUDY
    Ruimy, R.
    Akrich, B.
    Bourge, X.
    Boutoille, D.
    Brassac, I
    Castan, B.
    Levy-Bachelot, L.
    Mackosso, C.
    Tavares, Monteiro L.
    Mootien, J.
    Ruiz, F.
    Timsit, J. F.
    VALUE IN HEALTH, 2022, 25 (01) : S19 - S20
  • [23] How Important Are the Standard Measures in Assessing the Clinical Outcomes in Psoriatic Arthritis in Real-world Settings?
    Iannone, Florenzo
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (05) : 450 - 452
  • [24] Allergen immunotherapy: Clinical outcomes data from a real-world clinical practice
    Silva, Pedro
    Nogueira, Celia
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1016 - 1016
  • [26] Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings-A French Real-world Study
    Timsit, Jean-Francois
    Mootien, Joy
    Akrich, Brune
    Bourge, Xavier
    Brassac, Isabelle
    Castan, Bernard
    Mackosso, Carole
    Tavares, Linsay Monteiro
    Ruiz, Fabrice
    Boutoille, David
    Ruimy, Raymond
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [27] REAL WORLD OUTCOMES OF A NOVEL FECAL MICROBIOME REPLACMENT TREATMENT FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTICENTER STUDY
    Ritter, Timothy
    Rosenberg, Jonathan
    Hengel, Richard L.
    Krishnan, Sujatha
    Baker, Kathy A.
    Van Anglen, Lucinda J.
    Hanna, Kelly
    Guo, Amy
    Moosapanah, Mielad
    Garey, Kevin W.
    GASTROENTEROLOGY, 2024, 166 (05) : S578 - S579
  • [28] Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study
    Greystoke, A.
    Nawaz, A.
    Ferguson, S.
    Pabla, M.
    Sanjeevi, P.
    Bar-Ziv, O.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S299 - S300
  • [29] Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico
    De-la-Rosa-Martinez, Daniel
    Rivera-Buendia, Frida
    Cornejo-Juarez, Patricia
    Garcia-Pineda, Bertha
    Nevarez-Lujan, Carolina
    Vilar-Compte, Diana
    AMERICAN JOURNAL OF INFECTION CONTROL, 2022, 50 (11) : 1220 - 1225
  • [30] Contrasting methods to operationalize antibiotic exposure in clinical research: a real-world application on health care-associated Clostridioides difficile infection
    Webster, Jessica L.
    Eppes, Stephen
    Lee, Brian K.
    Harrington, Nicole S.
    Goldstein, Neal D.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2025,